
Cell Cycle/Checkpoint
Cell cycle/checkpoint inhibitors are compounds that disrupt the normal progression of the cell cycle, particularly at key regulatory checkpoints. These inhibitors are crucial for studying cell division, understanding cancer cell proliferation, and developing anti-cancer therapies. By targeting specific phases of the cell cycle, these inhibitors can induce cell cycle arrest, leading to apoptosis or senescence in rapidly dividing cells. At CymitQuimica, we offer a diverse range of high-quality cell cycle/checkpoint inhibitors to support your research in cancer biology, cell biology, and drug development.
Subcategories of "Cell Cycle/Checkpoint"
- Aurora Kinase(95 products)
- CDK(501 products)
- Cell Cycle Arrest(4 products)
- Chk(42 products)
- DYRK(48 products)
- Dynamin(23 products)
- Ferroptosis(215 products)
- HSP(169 products)
- Integrin(224 products)
- Kinesin(66 products)
- LIM Kinase(19 products)
- Microtubule Associated(262 products)
- PKC(102 products)
- PLK(28 products)
- ROCK(69 products)
- Rho(2 products)
- Wee1(15 products)
- c-Myc(69 products)
Show 10 more subcategories
Found 3485 products of "Cell Cycle/Checkpoint"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
XL-188
CAS:<p>XL-188: Potent, selective USP7 inhibitor, IC50 = 193 nM (domain), 90 nM (full). Boosts p53, p21; degrades HDM2. Unique among DUB inhibitors.</p>Formula:C32H42N6O4Color and Shape:SolidMolecular weight:574.71FRα-IN-1
CAS:<p>FRα-IN-1 (Compound 4) is a tumour targeting agent. FRα-IN-1 exhibits selective anti-cancer effects on FRα and FRβ expressing cells.</p>Formula:C21H24N6O6Color and Shape:SolidMolecular weight:456.45Nucleoside-Analog-1
CAS:<p>Nucleoside-Analog-1 is a 4′-Azidocytidine analogue, used to against Hepatitis C virus replication.</p>Formula:C9H9N5O5Purity:98%Color and Shape:SolidMolecular weight:267.2L-Fd4A
CAS:<p>L-Fd4A (compound 36) is an adenine derivative with anti-HIV (EC50=1.5μM) and anti-HBV (EC50=1.7μM) effects, low cytotoxicity.</p>Formula:C10H10FN5O2Color and Shape:SolidMolecular weight:251.22CLK1-IN-2
<p>CLK1-IN-2: Metabolically stable, Clk1-selective inhibitor; IC50=1.7nM; useful in tumor, Duchenne MD, HIV-1, influenza research.</p>Formula:C16H12Cl2N2O2SColor and Shape:SolidMolecular weight:367.25TDRL-X80
CAS:<p>TDRL-X80 inhibits XPA DNA binding; effective on single, double, and cisplatin-damaged DNA; IC50: 18-29 μM (FP), 21-39 μM (ELISA).</p>Formula:C23H15ClN2O6Color and Shape:SolidMolecular weight:450.83Metioprim
CAS:<p>Metioprim is a competitive bacterial dihydrofolate reductases inhibitor.</p>Formula:C14H18N4O2SPurity:98%Color and Shape:SolidMolecular weight:306.38CCT068127
CAS:<p>CCT068127 is a potent CDK2 and CDK9 inhibitor.</p>Formula:C19H27N7OColor and Shape:SolidMolecular weight:369.46L-Cytidine
CAS:<p>L-Cytidine, pyrimidine nucleoside in RNA, regulates glial glutamate, brain lipids, catecholamines, and mitochondria.</p>Formula:C9H13N3O5Color and Shape:SolidMolecular weight:243.22hDHODH-IN-5
CAS:<p>hDHODH-IN-5 is an inhibitor of human dihydroorotate dehydrogenase (hDHODH, IC50 = 0.91 μM).</p>Formula:C21H21F3N2O2Purity:99.55%Color and Shape:SolidMolecular weight:390.4DHODH-IN-13
CAS:<p>DHODH-IN-13 is an inhibitor of DHODH with IC50 of 4.3 μM for rat liver. DHODH-IN-13 can be used in studies about rheumatoid arthritis.</p>Formula:C10H6F3N3O3Purity:99.66%Color and Shape:SolidMolecular weight:273.17(S)-CR8
CAS:<p>(S)-CR8 is an effective second-generation cyclin-dependent kinase inhibitor.</p>Formula:C24H29N7OColor and Shape:SolidMolecular weight:431.53Eg5 Inhibitor V, trans-24
CAS:<p>Eg5 Inhibitor V, trans-24 is a specific and potent Eg5 inhibitor that can be used in cancer research with an IC50 value of 0.65 uM.</p>Formula:C26H21N3O3Purity:99.75%Color and Shape:SolidMolecular weight:423.46BPKDi
CAS:<p>BPKDi is a potent and selective inhibitor of PKD (protein kinase D).</p>Formula:C21H28N6OPurity:98%Color and Shape:SolidMolecular weight:380.49hDHODH-IN-3
CAS:<p>hDHODH-IN-3 is an inhibitor of human dihydroorotate dehydrogenase with a pMIC50 value of 8.6. hDHODH-IN-3 can inhibit measles virus replication.</p>Formula:C18H19BrN4O2Purity:99.871%Color and Shape:SolidMolecular weight:403.27BMVC
CAS:<p>BMVC is a potent G-quadruplex (G4) stabilizer and a selective telomerase inhibitor (IC50: ~0.2 μM) with anticancer activities.</p>Formula:C28H25I2N3Color and Shape:SolidMolecular weight:657.33Aloisine A
CAS:<p>Aloisine A, a CDK/GSK-3 inhibitor with IC50: Cdk1/B-150nM, Cdk2/A-120nM, Cdk2/E-400nM, Cdk5/25-200nM, Cdk5/35-160nM, GSK-3α-500nM, GSK-3β-650nM, JNK-3-10μM.</p>Formula:C16H17N3OPurity:98%Color and Shape:SolidMolecular weight:267.33CDK2-IN-11
CAS:<p>CDK2-IN-11 inhibits CDK2 (IC50: 6.4 μM) and targets hCA II, IX, XII (Ki: 23.4-56.3 nM); suited for cancer research.</p>Formula:C18H14ClN7O2SColor and Shape:SolidMolecular weight:427.87TP1287
CAS:<p>TP-1287 is an oral phosphate prodrug of the CDK9 inhibitor, alvocidib.</p>Formula:C21H21ClNO8PColor and Shape:SolidMolecular weight:481.82(S)-LY3177833 hydrate
CAS:<p>(S)-LY3177833 ((S)-Example 2) hydrate, an orally active CDC7 kinase inhibitor, exhibits extensive in vitro anticancer efficacy.</p>Formula:C16H14FN5O2Color and Shape:SolidMolecular weight:327.31Bofumustine
CAS:<p>Bofumustine is a chloroethyl nitrosourea with anti tumor properties.</p>Formula:C18H21ClN4O9Color and Shape:SolidMolecular weight:472.83AS-136A
CAS:<p>AS-136A is an orally active MV RdRp inhibitor with antiviral activity that inhibits measles virus and blocks viral RNA synthesis.</p>Formula:C17H19F3N4O3SPurity:98.52%Color and Shape:SolidMolecular weight:416.42Levoleucovorin disodium
CAS:<p>Levoleucovorin disodium is the sodium salt of the enantiomerically active form of Folinic Acid.</p>Formula:C20H21N7Na2O7Purity:98%Color and Shape:SolidMolecular weight:517.41Nitracrine
CAS:<p>Nitracrine: a 1-nitroacridine, hypoxia-selective, anti-tumor agent; inhibits RNA synthesis, binds DNA reversibly and forms covalent adducts.</p>Formula:C18H20N4O2Purity:98%Color and Shape:SolidMolecular weight:324.38ProTAME
CAS:<p>ProTAME inhibits APC/CFzr & APC/CCdc20, enhances cell death with doxorubicin/etoposide in primary/MM cells, especially after TOPIIα upregulation.</p>Formula:C34H38N4O12SPurity:98%Color and Shape:SolidMolecular weight:726.75Braco-19 trihydrochloride
CAS:<p>BRACO19 3HCl inhibits telomerase, blocking its capping function, and prevents HAdV viral replication.</p>Formula:C35H46Cl3N7O2Purity:98.74%Color and Shape:SolidMolecular weight:703.14DDD100097
CAS:<p>DDD100097 is a N-myristoyltransferase inhibitor with potential inhibitory effects on Trypanosoma brucei, which can be used to study neurological disorders.</p>Formula:C22H30Cl2F2N4O2SPurity:98.89%Color and Shape:SolidMolecular weight:523.47DHODH-IN-8
CAS:<p>DHODH-IN-8 is a DHODH inhibitor with antimalarial properties, IC50: 0.13 μM (human), 47.4 μM (P. falciparum); Ki: 0.016 μM (human), 5.6 μM (P. falciparum).</p>Formula:C17H13ClN2O2Purity:99.78%Color and Shape:SolidMolecular weight:312.75LY 222306
CAS:<p>LY 222306 is a glycinamide ribonucleotide formyltransferase (GARFT) inhibitor with a Ki of 0.77 nM.</p>Formula:C19H23N5O7Purity:98%Color and Shape:SolidMolecular weight:433.42CDK5 inhibitor 20-223
CAS:<p>CDK5 inhibitor 20-223 is a potent CDK2/CDK5 inhibitor,anti-Colorectal Cancer (CRC), inhibiting cell migration and inducing cell cycle arrest.</p>Formula:C19H19N3OColor and Shape:SolidMolecular weight:305.372-Fluoroadenine
CAS:<p>2-Fluoroadenine (NSC-27364) has toxicity in nonproliferating and proliferating tumor cells. 2-Fluoroadenine can be used for anticancer studies.</p>Formula:C5H4FN5Purity:98.84% - 99.62%Color and Shape:White To Light Yellow Crystal PowderMolecular weight:153.12Ipivivint
CAS:<p>Ipivivint: orally active, potent CLK inhibitor; hinders CLK1, CLK2, & CLK3; curbs Wnt signaling & SRSF phosphorylation for cancer research.</p>Formula:C26H21FN8Color and Shape:SolidMolecular weight:464.5OM-137
CAS:<p>OM137 inhibits Aurora kinases, impedes cell growth at high doses, and enhances low-dose paclitaxel effects.</p>Formula:C13H14N4O3SColor and Shape:SolidMolecular weight:306.34VRX-0466617
CAS:<p>VRX-0466617 is a novel selective Chk2 inhibitor.</p>Formula:C19H20BrN5O2SColor and Shape:SolidMolecular weight:462.36CDK2-IN-12
CAS:<p>CDK2-IN-12 (10b), potent CDK2 inhibitor, IC50: 11.6 μM; inhibits hCA I/II/IX/XII, KI: 3534/638.4/44.3/48.8 nM; anti-cancer properties.</p>Formula:C20H17N9O2SColor and Shape:SolidMolecular weight:447.47CDK8-IN-6
CAS:<p>CDK8-IN-6 (compound 9) is a potent inhibitor of cyclin-dependent kinase 8 (CDK8) (Kd: 13 nM), CDK8-IN-6 showed potential research value in AML cancers.</p>Formula:C26H37ClN2Color and Shape:SolidMolecular weight:413.04KH-CB19
CAS:<p>KH-CB19 is an effective and highly specific inhibitor of the CDC2-like kinase isoforms 1 and 4 (CLK1/CLK4).</p>Formula:C15H13Cl2N3O2Color and Shape:SolidMolecular weight:338.19Litronesib Racemate
CAS:<p>Litronesib is a selective, allosteric inhibitor of kinesin Eg5.Litronesib (Racemate) is the racemate of litronesib.</p>Formula:C23H37N5O4S2Color and Shape:SolidMolecular weight:511.7Dyrk1A-IN-3
CAS:<p>Dyrk1A-IN-3 is a selective DYRK1A inhibitor with an IC50 of 76 nM, useful for neurodegenerative disease research.</p>Formula:C18H16N6Color and Shape:SolidMolecular weight:316.363,6-DMAD dihydrochloride
CAS:<p>3,6-DMAD dihydrochloride: Potent IRE1α-XBP1s inhibitor, affects IL-6 secretion and RNase activity, used in cancer research.</p>Formula:C22H33Cl2N5Color and Shape:SolidMolecular weight:438.44Synucleozid
CAS:<p>Synucleozid is a potent the SNCA mRNA inhibitor that encodes α-synuclein protein (IC50=1.5 μM), has the potential for the investigation of Parkinson’s disease.</p>Formula:C22H20N6Purity:98%Color and Shape:SolidMolecular weight:368.43PF-4950834
CAS:<p>PF-4950834, a ATP-competitive, selective Rho kinase inhibitor, provides therapeutic benefits in chronic inflammatory diseases.</p>Formula:C21H19N3O2Purity:98%Color and Shape:SolidMolecular weight:345.39GP29
CAS:<p>GP29 is a Type II kinase inhibitor of the IRE1α endoribonuclease that acts by targeting the ATP-binding pocket of IRE1α.</p>Formula:C33H28F3N5O3Purity:98%Color and Shape:SolidMolecular weight:599.6PV-1115
CAS:<p>PV-1115 is an effective and highly selective inhibitor of the Chk2.</p>Formula:C20H19N7O3Purity:98%Color and Shape:SolidMolecular weight:405.41HIV-1 inhibitor-43
CAS:<p>HIV-1 Inhibitor-43 suppresses HIV-1, with EC50: 21.3 nM (Y188L), 6.2 nM (K103N-Y181C), <0.7 nM (K103N/Y181C), and lowers HIV RNA/p24 protein.</p>Formula:C24H21ClN2O4SColor and Shape:SolidMolecular weight:468.95BMVC2
CAS:<p>BMVC2 (o-BMVC), a carbazole derivative of BMVC, is a G-quadruplex (G4) stabilizer.</p>Formula:C28H25I2N3Color and Shape:SolidMolecular weight:657.33BMH-22
CAS:<p>BMH-22 is an RNA polymerase I inhibitor that acts by causing nucleolar stress and showing potent anticancer activity across many tumor types.</p>Formula:C16H17N3Color and Shape:SolidMolecular weight:251.33MSC-1186
CAS:<p>MSC-1186 selectively inhibits SRPKs—IC50: 2.7nM (SRPK1), 81nM (SRPK2), 0.6nM (SRPK3)—for cancer research.</p>Formula:C19H17ClFN7O2SColor and Shape:SolidMolecular weight:461.9Bis-Pro-5FU
CAS:<p>Bis-Pro-5FU enhances oral uptake and safety of 5-FU, an anti-cancer drug for colorectal and pancreatic tumors.</p>Formula:C10H7FN2O2Color and Shape:SolidMolecular weight:206.17Carbonic anhydrase inhibitor 14
CAS:<p>CA inhibitor 14 blocks hCA I/II/IX/XII (K i of 1203/99.7/9.4/27.7 nM) and CDK2 (IC50: 20.3 μM), showing antitumor effects.</p>Formula:C18H17N7O2SColor and Shape:SolidMolecular weight:395.442-Keto-D-galactose
CAS:<p>2-Keto-D-galactose inhibits DNA synthesis and inhibits the proliferation of in vitro grown Ehrlich ascites tumor cells.</p>Formula:C6H10O6Purity:98%Color and Shape:SolidMolecular weight:178.14Fozivudine tidoxil
CAS:<p>Fozivudine tidoxil, a reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection.</p>Formula:C35H64N5O8PSColor and Shape:SolidMolecular weight:745.95(Rac)-Managlinat dialanetil
CAS:<p>Managlinat dialanetil, an orally available and potent inhibitor of fructose 1,6-bisphosphatase (FBPase) used in research 2 type diabetes.</p>Formula:C21H33N4O6PSPurity:98.52%Color and Shape:SolidMolecular weight:500.55DHODH-IN-12
CAS:<p>DHODH-IN-12 is a leflunomide derivative and a weak dihydrorotate dehydrogenase (DHODH) inhibitor with a pKa of 5.07.</p>Formula:C10H9N3O2Purity:99.53%Color and Shape:SolidMolecular weight:203.2CAP-53194
CAS:<p>CAP-53194 is a selective Plk1 inhibitor.</p>Formula:C21H14N6O5Purity:98%Color and Shape:SolidMolecular weight:430.37CGP 53353
CAS:<p>CGP 53353 (DAPH-7) is a PKC inhibitor with inhibitory effects on PKCβII and PKCβI and can be used to study atherosclerosis.</p>Formula:C20H13F2N3O2Purity:98.11%Color and Shape:SolidMolecular weight:365.33Aditoprime
CAS:<p>Aditoprime inhibits bacterial growth by blocking DHFR, effective against L.casei and E.coli with IC50 of 520/47 nM.</p>Formula:C15H21N5O2Color and Shape:SolidMolecular weight:303.36GSK-3008348
CAS:<p>GSK-3008348 is an antagonist of integrin alpha(v)beta6.</p>Formula:C29H37N5O2Purity:99.547%Color and Shape:SolidMolecular weight:487.64Mivobulin Isethionate
CAS:<p>Mivobulin, a tubulin inhibitor (CI-980), may treat glioma, melanoma, prostate, and ovarian cancer, targeting colchicine-binding site.</p>Formula:C19H25N5O6SPurity:98%Color and Shape:SolidMolecular weight:451.5PKC-9
CAS:<p>PKC-9 is a PKC-zeta inhibitor 9.</p>Formula:C25H25N7Color and Shape:SolidMolecular weight:423.51DHODH-IN-20
CAS:<p>Dhodh-in-20 (Compound 133), a potent DHODH inhibitor, may help study acute myeloid leukemia and inhibit tumor growth.</p>Formula:C24H25F4N3O3Color and Shape:SolidMolecular weight:479.47Picoplatin
CAS:<p>Picoplatin, an anti-cancer agent overcoming platinum resistance, alkylates DNA to block replication, transcription, and induce apoptosis.</p>Formula:C6H10Cl2N2PtPurity:98%Color and Shape:SolidMolecular weight:376.14HHL-6
CAS:<p>HHL-6 is a c-Fos and BDNF protein expression modulator.</p>Formula:C19H26N2O3Color and Shape:SolidMolecular weight:330.42Metralindole HCl
CAS:<p>Metralindole is a reversible monoamine oxidase A (RIMA) inhibitor, it was investigated as a potential antidepressant.</p>Formula:C15H18ClN3OPurity:98%Color and Shape:SolidMolecular weight:291.78HR22C16
CAS:<p>HR22C16 is an effective, selective, and cell-permeable mitotic kinesin Eg5 inhibitor.</p>Formula:C23H23N3O3Color and Shape:SolidMolecular weight:389.45JFN05510
CAS:<p>Compound: 3'-O-tert-BDMS-5'-O-DMT-N2-IBG 2'-CE phosphoramidite; has anticancer properties and activates enzymes.</p>Formula:C50H68N7O9PSiColor and Shape:SolidMolecular weight:970.18HIPP
CAS:<p>HIPP is a highly selective inhibitor of antineoplastic CtBP.</p>Formula:C9H9NO3Color and Shape:SolidMolecular weight:179.17NPD9948
CAS:<p>NPD9948 is a competitive inhibitor of MTH1.</p>Formula:C13H14N6Color and Shape:SolidMolecular weight:254.29LDN-209929
CAS:<p>LDN-209929 2HCl is a potent and selective inhibitor of haspin kinase.</p>Formula:C17H17ClN2OSColor and Shape:SolidMolecular weight:332.85DYRKi
CAS:<p>DYRKi is a nontoxic, DYRK1-selective inhibitor.</p>Formula:C20H13F3N4O2SColor and Shape:SolidMolecular weight:430.4BIPM
CAS:<p>BIPM inhibits ROCK2, alters SH-SY5Y cell migration, actin fibers, neurite length, and reduces cofilin phosphorylation.</p>Formula:C23H22N2O3Color and Shape:SolidMolecular weight:374.43REV7/REV3L-IN-1
CAS:<p>REV7/REV3L-IN-1 is a inhibitor of REV7/REV3L interaction(IC50 of 78 μM),</p>Formula:C19H21N3O3SPurity:98%Color and Shape:SolidMolecular weight:371.45NSC47924
CAS:<p>NSC47924 is a laminin receptor (LR) inhibitor.</p>Formula:C18H17NO2Purity:98%Color and Shape:SolidMolecular weight:279.33AB-182
CAS:<p>AB-182 is an aziridine derivative with antitumor activity.</p>Formula:C11H22N3O4PColor and Shape:SolidMolecular weight:291.28Ro 43-5054
CAS:<p>Ro 43-5054 is a small molecular, noncyclic peptidomimetic inhibitor.</p>Formula:C24H27N5O7Purity:98%Color and Shape:SolidMolecular weight:497.5ROCK-IN-D1
CAS:<p>ROCK-IN-D1 is an effective and selective inhibitor of ROCK.</p>Formula:C22H27N5O2SPurity:98%Color and Shape:SolidMolecular weight:425.55SNX2-1-108
CAS:<p>SNX2-1-108 is a selective CDK8 and CDK19 inhibitor.</p>Formula:C21H16N4Purity:98%Color and Shape:SolidMolecular weight:324.38L-Guanosine
CAS:<p>L-Guanosine is the L-configuration of Guanosine. Guanosine is a purine nucleoside that has anti-herpesvirus activity [1] [2].</p>Formula:C10H13N5O5Color and Shape:SolidMolecular weight:283.24LIMK-IN-14
CAS:<p>LIMK-IN-14 is an effective and selective inhibitor of LIMK.</p>Formula:C22H27N7O3Purity:98%Color and Shape:SolidMolecular weight:437.49Fosteabine
CAS:<p>Fosteabine is an oral and prodrug analog of cytarabine. It is resistant to deoxycytidine deaminase.</p>Formula:C27H50N3O8PPurity:98%Color and Shape:SolidMolecular weight:575.67Denopterin
CAS:<p>Denopterin is an antineoplastic agent.</p>Formula:C21H23N7O6Purity:98%Color and Shape:SolidMolecular weight:469.45UIAA-II-232
CAS:<p>UIAA-II-232 (compound 19b) is a potent inhibitor of DNA gyrase catalytic (IC 50= 3.5 μM).</p>Formula:C20H24FN5O3Color and Shape:SolidMolecular weight:401.43Protein kinase D inhibitor 1
CAS:<p>Protein kinase D inhibitor 1 (17m) is a potent pan-PKD suppressant with IC50 of 17-35 nM, targeting cortactin phosphorylation.</p>Formula:C19H21N7Color and Shape:SolidMolecular weight:347.42BAY-707
CAS:<p>BAY-707: tolerable in mice, no anticancer efficacy; potent, selective MTH1 inhibitor, IC50 = 2.3 nM; good PK profile.</p>Formula:C15H20N4O2Purity:98%Color and Shape:SolidMolecular weight:288.34Cdc7-IN-14
CAS:<p>Cdc7-IN-14 (compound 82) is a potent CDC7 inhibitor with an IC50 < 1 nM, promising for cancer research.</p>Formula:C18H20N4O2SColor and Shape:SolidMolecular weight:356.441-Acetyl-3-o-toluyl-5-fluorouracil
CAS:<p>1-Acetyl-3-o-toluyl-5-fluorouracil is a potent antineoplastic agent.</p>Formula:C14H11FN2O4Purity:98%Color and Shape:SolidMolecular weight:290.25Rho-Kinase-IN-2
CAS:<p>Rho-Kinase-IN-2, an oral ROCK inhibitor (IC50=3nM), penetrates the CNS; potential in Huntington's research.</p>Formula:C20H25FN4O2Color and Shape:SolidMolecular weight:372.44Rabacfosadine succinate
CAS:<p>Rabacfosadine succinate is the acyclic nucleoside phosphonate PMEG double prodrug.</p>Formula:C25H41N8O10PPurity:98%Color and Shape:SolidMolecular weight:644.623Thiamiprine
CAS:<p>Thiamiprine is an agent with the activity of antineoplastic.</p>Formula:C9H8N8O2SColor and Shape:SolidMolecular weight:292.28Meturedepa
CAS:<p>Meturedepa is an antineoplastic agent.</p>Formula:C11H22N3O3PPurity:98%Color and Shape:SolidMolecular weight:275.28RK-9123016
CAS:<p>RK-9123016 is a SIRT2 inhibitor.</p>Formula:C16H18N6O3SPurity:99.65%Color and Shape:SolidMolecular weight:374.42MK-0668
CAS:<p>MK-0668 is a very potent and orally active very late antigen-4 antagonist.</p>Formula:C31H30Cl2N6O6SColor and Shape:SolidMolecular weight:685.58BI-831266
CAS:<p>BI-831266 is a potent and selective Aurora kinase B inhibitor.</p>Formula:C27H38ClN7O2Color and Shape:SolidMolecular weight:528.09BzDANP
CAS:<p>BzDANP is a modulator of pre-miR-29a maturation by Dicer.</p>Formula:C18H24N6Color and Shape:SolidMolecular weight:324.42L 703014
CAS:<p>L 703014 is an antagonist of the fibrinogen receptor.</p>Formula:C24H34N4O4Purity:98%Color and Shape:SolidMolecular weight:442.55SEC inhibitor KL-2
CAS:<p>KL-2: potent SEC inhibitor, selectively disrupts AFF4-CCNT1, dose-dependent, Ki: 1.50 μM.</p>Formula:C17H13ClFNO3Purity:99.86%Color and Shape:SolidMolecular weight:333.74BMH-23
CAS:<p>BMH-23 is an RNA polymerase I inhibitor that acts by causing nucleolar stress and showing potent anticancer activity across many tumor types.</p>Formula:C15H15N3Purity:98%Color and Shape:SolidMolecular weight:237.3(R)-DRF053 dihydrochloride
CAS:<p>cdk/CK1 inhibitor,potent and ATP-competitive</p>Formula:C23H29Cl2N7OPurity:98%Color and Shape:SolidMolecular weight:490.43AM-TS23
CAS:<p>AM-TS23 is used as a DNA polymerase lambda and beta inhibitor.</p>Formula:C17H12N2O3S3Purity:98%Color and Shape:SolidMolecular weight:388.48Scaff10-8
CAS:<p>Scaff10-8 blocks AKAP-Lbc-RhoA, aiding aquaporin-2 movement in kidney cells.</p>Formula:C22H18O6Purity:98%Color and Shape:SolidMolecular weight:378.37
